Abstract：【Objective】 To investigate the expression and clinical significance of Supervillin(SVIL) and interleukin-1β(IL-1β) proteins in epithelial ovarian cancer(EOC) tissues. 【Methods】 A total of ovarian epithelial tumor tissue specimens resected surgically and confirmed by pathological examination in our hospital from January 2010 to June 2022 were selected, including 40 cases of EOC tissue specimens(group A), 20 cases of ovarian epithelial borderline tumor tissue specimens(group B) and 20 cases of ovarian epithelial benign tumor tissue specimens(group C). Immunohistochemistry was used to detect the expression levels of SVIL and IL-1β proteins in each group, and their clinical significance was analyzed. 【Results】 Immunohistochemical results showed that the positive expression rates of SVIL and IL-1β proteins in group A and group B were significantly higher than those in group C, with statistically significant differences(P<0.05), while there were no statistically significant differences in the positive expression rates of SVIL and IL-1β proteins between group A and group B(P>0.05). The positive expression rates of SVIL and IL-1β proteins in EOC tissues were correlated with the degree of tissue differentiation and clinical stage(P<0.05), but not significantly correlated with age, histological type, presence of ascites and presence of lymph node metastasis(P>0.05). The expression of SVIL protein was positively correlated with that of IL-1β protein in EOC tissue specimens(r=0.373, P=0.018).【Conclusion】 SVIL and IL-1β proteins may be involved in the occurrence and development of EOC, and there is a significant correlation between them.
刘瑜, 陈颖. Supervillin和IL-1β蛋白在上皮性卵巢癌组织中的表达及其临床意义*[J]. 医学临床研究, 2026, 43(1): 9-11.
LIU Yu, CHEN Ying. Expression and Clinical Significance of Supervillin and IL-1β Proteins in Epithelial Ovarian Cancer Tissues. JOURNAL OF CLINICAL RESEARCH, 2026, 43(1): 9-11.
[1] 朱雨.贝伐珠单抗联合TC方案治疗卵巢癌患者的临床疗效及对患者血清HE4、CA125水平的影响[J].医学临床研究,2025,42(4):604-607.
[2] KURMAN R J, SHIH IE M. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded [J].Am J Pathol,2016, 186(4): 733-747.
[3] FENG C X, KOU L, YIN P Y, et al. Excessive activation of IL-33/ST2 in cancer-associated fibroblasts promotes invasion and metastasis in ovarian cancer [J].Oncol Lett,2022, 23(5): 158.
[4] AHMED A B, ZIDI S, SGHAIER I, et al. Common variants in IL-1RN, IL-1beta and TNF-alpha and the risk of ovarian cancer: a case control study [J].Cent Eur J Immunol,2017, 42(2): 150-155.
[5] BONDONG S, KIEFEL H, HIELSCHER T, et al. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kappaB activation [J].Ann Oncol,2012, 23(7): 1795-1802.
[6] ZHANG Q, LENARDO M J, BALTIMORE D. 30 years of NF-κB: a blossoming of relevance to human pathobiology [J].Cell,2017, 168(1-2): 37-57.
[7] JI Z, HE L Z, REGEV A, et al. Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers [J].Proc Natl Acad Sci U S A,2019, 116(19): 9453-9462.
[8] ZHOU J, QUE Y H, PAN L H, et al. Supervillin contributes to LPS-induced inflammatory response in THP-1 cell-derived macrophages [J].Inflammation,2022,45(1):356-371.
[9] XIE X H, YANG M Y, DING Y L, et al. Microbial infection, inflammation and epithelial ovarian cancer [J].Oncol Lett,2017, 14(2): 1911-1919.
[10] SCHAUER I G, ZHANG J, XING Z, et al. Interleukin-1beta promotes ovarian tumorigenesis through a p53/NF-kappaB-mediated inflammatory response in stromal fibroblasts [J].Neoplasia,2013, 15(4): 409-420.
[11] CROWLEY J L, SMITH T C, FANG Z, et al. Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency [J].Mol Biol Cell,2009, 20(3): 948-962.
[12] GUDKOV A V, KOMAROVA E A. p53 and the carcinogenicity of chronic inflammation [J].Cold Spring Harb Perspect Med,2016,6(11):a026161.
2026, Vol. 43 
